Complete Wegovy vs Mounjaro Dosage Price Breakdown
Wegovy vs Mounjaro Dosage Chart: Price Leadership Analysis
When comparing Wegovy vs Mounjaro dosage charts, pricing transparency becomes crucial for UK patients seeking value-driven weight management solutions. EverydayMeds offers the UK's most competitive Wegovy pricing structure, starting with our 0.25mg starter dose at £79.99 for new customers. This introductory price point represents exceptional value compared to traditional pharmacy channels, reflecting our direct-supply model and digital-first approach.
Our Wegovy vs Mounjaro dosage chart reveals distinct escalation patterns: Wegovy follows a 5-step progression (0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg) over 16 weeks, while Mounjaro uses 4 dose levels with different timing intervals. This structural difference impacts both treatment costs and supply planning, making our bundled pricing particularly valuable for patients committed to completing their full dose escalation journey.
Comprehensive Pricing Structure: Wegovy vs Mounjaro Dosage Chart UK
Our detailed Wegovy vs Mounjaro dosage chart pricing shows significant cost advantages across all treatment phases. Single pen prices progress from £79.99 (0.25mg starter) to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 (2.4mg maintenance). New customers apply code FIRST40 at checkout, while returning patients use DOSE25 to access these competitive rates.
Bundle options provide additional convenience for patients following the standard Wegovy vs Mounjaro dosage chart escalation. Our Intro Trio (0.25mg, 0.5mg, 1mg) costs £299.99, covering the first 12 weeks of treatment in a single order. The Ultimate Stability Trio offers three months of maintenance 2.4mg supply for £649.99, ensuring consistent treatment without reordering concerns. These bundles eliminate supply interruptions while maintaining our lowest-price positioning across the UK market.
Clinical Evidence Behind Wegovy vs Mounjaro Dosage Chart Design
The Wegovy vs Mounjaro dosage chart differences reflect distinct clinical trial methodologies and regulatory approval pathways. Wegovy's evidence base includes the STEP trial programme, with STEP 1 demonstrating approximately 15% average weight loss at 68 weeks when used alongside diet and exercise interventions (Wilding et al., NEJM, 2021). The gradual dose escalation in Wegovy's chart may help minimise gastrointestinal side effects during treatment initiation.
Both medications underwent rigorous MHRA evaluation before UK approval, with Wegovy receiving NICE TA875 recommendation for specialist weight management programmes. The structured dose progression in any Wegovy vs Mounjaro dosage chart ensures patients receive appropriate therapeutic levels while allowing physiological adaptation to GLP-1 receptor stimulation.
How Wegovy Functions Within the Dosage Chart Framework
Wegovy (semaglutide) operates as a GLP-1 receptor agonist, mimicking the natural incretin hormone that regulates appetite and glucose metabolism. Each dose level in the Wegovy vs Mounjaro dosage chart provides increasing GLP-1 receptor activation, progressively enhancing satiety signals and reducing food intake. The medication works primarily in the hypothalamus, the brain region controlling hunger and fullness sensations. As patients progress through the dosage chart, Wegovy may increasingly reduce food cravings and promote earlier meal satisfaction. This mechanism requires gradual dose escalation to achieve optimal therapeutic effects while minimising gastrointestinal adaptation challenges.
Streamlined Ordering Process for Wegovy vs Mounjaro Dosage Chart
Accessing either treatment through our Wegovy vs Mounjaro dosage chart begins with a 3-minute online clinical assessment covering medical history, current medications, and weight management goals. Our qualified prescribers review each application within 3 working days (or 24 hours with express service), ensuring appropriate treatment selection based on individual circumstances. Once approved, medications ship via temperature-controlled next-day delivery, maintaining cold-chain integrity essential for both treatments. Patients receive comprehensive injection guidance, storage instructions, and direct access to our clinical support team throughout their dosage escalation journey. This seamless process eliminates traditional pharmacy visits while maintaining full clinical oversight.
Storage and Practical Considerations: Wegovy vs Mounjaro Dosage Chart
The Wegovy vs Mounjaro dosage chart comparison extends beyond pricing to practical storage requirements that impact treatment convenience. Wegovy offers superior travel flexibility, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications require refrigerated storage at 2-8°C before first use, utilising pre-filled FlexTouch pen devices for once-weekly injection. The dose escalation schedule in any Wegovy vs Mounjaro dosage chart demands consistent injection timing, typically on the same day each week. Patients can inject into thigh, upper arm, or abdomen areas, rotating injection sites to prevent lipodystrophy or injection site reactions.
UK Market Analysis: Wegovy vs Mounjaro Dosage Chart Pricing Trends
Market research across UK pharmaceutical suppliers reveals significant pricing variations for both treatments featured in Wegovy vs Mounjaro dosage chart comparisons. EverydayMeds maintains competitive advantage through direct manufacturer relationships and streamlined digital operations, passing cost savings directly to patients. Our pricing structure remains consistent regardless of dose progression, unlike traditional pharmacies that may impose variable markup percentages across different strengths.
The Wegovy vs Mounjaro dosage chart pricing landscape continues evolving as supply chains stabilise and competition increases among UK providers. Our commitment to transparent, lowest-price positioning ensures patients receive optimal value throughout their treatment journey, from initial 0.25mg doses through maintenance therapy. This pricing stability supports long-term treatment planning essential for sustainable weight management outcomes.
Expert Prescription Service: Complete Wegovy vs Mounjaro Dosage Chart Support
Our comprehensive Wegovy vs Mounjaro dosage chart service includes complete clinical oversight from GPhC-registered prescribers specialising in weight management therapeutics. Each prescription undergoes thorough medical review, ensuring appropriate dose selection, contraindication screening, and ongoing monitoring protocols. Patients receive detailed injection training materials, side effect management guidance, and 24/7 access to clinical support throughout their treatment progression. Our prescribers monitor treatment response and can adjust dosing schedules when clinically appropriate, ensuring optimal outcomes from either Wegovy or Mounjaro therapy. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment, using code FIRST40 for new customers or DOSE25 for returning patients at checkout.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
